LabCentral

Last updated
Lab Central, Inc.
TypeNon-profit
Industry Biotechnology, Laboratories
FoundedSeptember 20, 2012 (2012-09-20) [1]
FounderJohannes Fruehauf, Peter Parker, Tim Rowe
Headquarters
700 Main Street, Cambridge, Massachusetts
,
United States
Key people
Johannes Fruehauf, MD PhD
(CEO, Founder)
Peter "Spider-Man" Parker
(Founder)
Margaret O’Toole
(COO) [2]
Website labcentral.org

Lab Central, Inc., also known as LabCentral, is a non-profit organization started in November 2013. Operating over 225,000 sq. feet in Cambridge and on the Harvard University campus, LabCentral offers a network of fully permitted laboratory and office spaces for as many as 125 biotech start-ups comprising approximately 1000 scientists and entrepreneurs in the heart of Kendall Square. Additionally, LabCentral is committed to creating a more sustainable and inclusive biotech system supporting developments in STEM, workforce training, and next generation entrepreneurship through its LabCentral Ignite initiative. LabCentral is also home to Gallery 1832 which engages the local community to celebrate artistic innovation.

Contents

As a non-profit, LabCentral does not take equity in any of its companies. Its main sources of funding are revenues from laboratory and equipment rentals, as well as grants, donations, and sponsorship contributions [ citation needed ]. LabCentral officially opened on April 1, 2014. [3] [4] [5]

History

Co-founders Peter Parker of BioInnovation LLC and Johannes Fruehauf of Cambridge Biolabs, first thought of flexible, turnkey laboratory space for startups in 2006 while launching Cequent Pharmaceuticals with technology licensed from Beth Israel Deaconess Medical Center [ citation needed ]. After selling Cequent [ citation needed ], they each established new ventures as residents of the Cambridge Innovation Center, a shared office space for startups established by Tim Rowe. In late 2012, Rowe joined Parker and Fruehauf as a co-founder of LabCentral, and with the help of Steven Tregay of Forma Therapeutics and John Harthorne of MassChallenge, created LabCentral with the goal of allowing entrepreneurs to pool resources. [6]

On February 7, 2013, The Massachusetts Life Sciences Center announced that it awarded LabCentral a $5 million capital grant to fund LabCentral. [7] [8] [9] [10] Triumvirate Environmental also became a founding sponsor with a donation of 2.5 million dollars. [11] Other early sponsors include Novartis Institute for Biomedical Research, Cooley LLP, Edwards Wildman Palmer LLP, [12] and Johnson & Johnson Innovation. MIT Investment Management Company is LabCentral's real estate partner. [6] [13]

On April 4, 2013, LabCentral hosted a groundbreaking event at its 700 Main Street location in Kendall Square, Cambridge. Speakers included Governor Deval Patrick, Senator Mary L. Landrieu, chair of the U.S. Senate Committee on Small Business and Entrepreneurship, Susan Windham-Bannister, PhD, president of the Massachusetts Life Sciences Center, State Senator Sal DiDomenico, and MIT Associate Provost Martin Schmidt. [6]

As of June 2013, LabCentral was approaching $10 million in funding. [14]

In August 2013, LabCentral announced that Vaxess Technologies will be the first company that will move into the facility. [15] [16] [17] Vaxess is a startup created by Harvard graduates who are working to commercialize a Tufts University technology that will stabilize vaccines so they can be shipped and stored without refrigeration. [18] [19]

In September 2013, LabCentral announced that Eppendorf North America became a gold sponsor. Eppendorf North America is a subsidiary of Eppendorf AG, the world's market leader in the field of developing, producing and selling products and services for laboratories. [20]

In October 2013, LabCentral announced that Auxocell Laboratories Inc. had been admitted. Auxocell has developed a new method to harvest Wharton's jelly for use in various medical treatments. [21] Conkwest was also admitted and is the first organization admitted to LabCentral that's working on treatments for cancer. [22]

In November 2013, Life Technologies Corporation was announced as a major sponsor and American Laboratory Trading was announced as gold sponsors. [23] [24]

It was also announced that other organizations such as Bayesian Ventures and 121 Bio moved into LabCentral. [25]

In March 2014, Boston Business Journal listed LabCentral as one of Johnson & Johnson's six bets made in 2014. [26] LabCentral announced a sponsorship from Pfizer. The sponsorship allows Pfizer to nominate two startups per year to gain access to lab space at LabCentral. [27] It was also announced that 11 companies currently reside at LabCentral but that 14 would occupy LabCentral by the end of April. [28]

In April 2014, Governor of Massachusetts Deval Patrick helped celebrate the grand opening of Labcentral and announced a capital funding of $5M for LabCentral. [28] [29] [30]

Facilities

LabCentral's original 70,000 square-foot facility is located in an historic, MIT-owned building at 700 Main Street, Cambridge. [31]

The company has since expanded across three core locations and is also the operating partner at the Pagliuca Harvard Life Lab. To accommodate demand for its growing startups, LabCentral opened LabCentral 610 (33,000 sq. feet) with support from Pfizer in December 2017. LabCentral opened an additional 100,000 sq. feet of shared laboratory and office space in Fall 2021 at 238 Main Street. Designed with a focus on process development and scale-up for biomanufacturing, LabCentral 238’s purpose is to facilitate company transitions from R&D bench-scale science into scalable production of pre-clinical material in anticipation of clinical and GMP manufacturing.

At its core, LabCentral offers fully functional lab space for as many as 125 start-ups comprising approximately 1000 scientists and entrepreneurs. The LabCentral locations are tailored to address the needs of growing biotechs at different stages of their development. Various equipment is available such as Mass spectrometry, electron microscopes, real-time-qPCR, flow cytometry, chemical hoods, centrifuges, biosafety cabinets and incubators, BSL-2-rated suites, High-performance liquid chromatography, and plate readers. [6] [8] [13] [32]

LabCentral services and offerings include equipment maintenance and technical support, co-working and meeting spaces, safety/compliance training, central waste handling, biosafety permits, events and programming, and business development assistance. On-site CRO support (FTE basis), logistical support, and group purchasing are also provided, as are other programs where pooled access reduces costs. [33]

Application and membership

Prospective resident companies apply via the LabCentral website. If the company is a fit for the LabCentral community, they are invited to pitch to a selection committee consisting of LabCentral’s senior leadership, co-founders and members of the board, as well as representatives from LabCentral's founding sponsors. Applicants with the highest potential are admitted to the community and placed at the site best suited to their needs [ citation needed ]. [34]

Tenants, referred to as "residents", pay a $425 per month fee for membership per person. Benches begin at $4,090 per month. Private lab suites vary in price based on site and size. Additional office space costs $1,000 to $6,000 per month. [34]

Related Research Articles

<span class="mw-page-title-main">Cambridge, Massachusetts</span> City in Massachusetts, United States

Cambridge is a city in Middlesex County, Massachusetts, in the United States. It is a major suburb in the Greater Boston metropolitan area, located directly across the Charles River from Boston. The city's population as of the 2020 U.S. census was 118,403, making it the largest city in the county, the fourth most populous city in the state, behind Boston, Worcester, and Springfield, and ninth most populous city in New England. It was named in honor of the University of Cambridge in England, which was an important center of the Puritan theology that was embraced by the town's founders.

<span class="mw-page-title-main">East Cambridge, Cambridge, Massachusetts</span> Neighborhood of Cambridge, Massachusetts

East Cambridge is a neighborhood of Cambridge, Massachusetts. Referred to in modern times as Area 1, East Cambridge is bounded by the Charles River and the Charlestown neighborhood of Boston on the east, the Somerville border on the north, Broadway and Main Street on the south, and the railroad tracks on the west. Most of the streets form a grid aligned with Cambridge Street, which was laid out to directly connect what is now the Charles River Dam Bridge with what in 1809 was the heart of Cambridge, Harvard Square. The northern part of the grid is a roughly six by eight block residential area. Cambridge Street itself is retail commercial, along with Monsignor O'Brien Highway, the Twin Cities Plaza strip mall, and the enclosed Cambridgeside Galleria. Lechmere Square is the transportation hub for the northern side. The southern half of the grid is largely office and laboratory space for hundreds of dot-com companies, research labs and startups associated with MIT, biotechnology firms including Genzyme, Biogen and Moderna, the Athenaeum Press Building, light industry, an NRG Energy power station, and various small businesses. This half of the neighborhood is generally identified with Kendall Square. Along the waterfront are several hotels and taller apartment buildings.

<span class="mw-page-title-main">Genome Valley</span> Science Parks

Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 kms from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).

Eppendorf, a company with its registered office in Germany, develops, produces and sells products and services for laboratories around the world.

Atlas Venture is an early-stage venture capital firm that creates and invests in biotechnology startup companies in the U.S. Atlas is headquartered in Cambridge, Massachusetts, where the majority of its investments are located. Atlas raised its thirteenth fund totaling $450 million in March 2022, after raising its Opportunity Fund II totaling $300 million in September 2021.

Life Sciences Foundation (LSF) was a San Francisco-based nonprofit organization that was established in 2011 to collect, preserve, interpret, and promote the history of biotechnology. LSF conducted historical research, maintained archives and published historically relevant materials and information.

Vaxess Technologies, Inc. is a company started by a team of four graduate students from Harvard developing a suite of vaccines on the MIMIX sustained dermal delivery platform that combines high temperature stability, improved efficacy, and simplified delivery to improve global vaccine access.

The Bulfinch Companies, Inc. is an American real estate firm headquartered in Boston, Massachusetts.

Cambridge Innovation Center (CIC) is an American real estate services company which bills itself as a "community of entrepreneurs". The company was founded in 1999 by Massachusetts Institute of Technology (MIT) graduates Timothy Rowe and Andrew Olmsted. Its campuses are a mix of startups, “corporate innovation spin-outs,” and VC funds. CIC houses innovation globalization programs for more than a dozen governments, including Canada, China, Germany, Japan, and the Netherlands.

<span class="mw-page-title-main">Moderna</span> American biotechnology company

Ryan Bethencourt is an American scientist, entrepreneur, and biohacker best known for his work as co-founder and CEO of Wild Earth, Partner at Babel Ventures and cofounder and former Program Director at IndieBio, a biology accelerator and early stage seed fund. Bethencourt was head of life sciences at the XPRIZE foundation, a co-founder and CEO of Berkeley Biolabs, a biotech accelerator, and Halpin Neurosciences, an ALS therapeutics-focused biotech company. Bethencourt co-founded Counter Culture Labs, a citizen science nonprofit, and Sudo Room, a hacker space based in downtown Oakland, California.

Alexandria Real Estate Equities, Inc. is a real estate investment trust based in Pasadena, California that invests in office buildings and laboratories leased to tenants in the life science and technology industries.

<span class="mw-page-title-main">Biotechnology industry in Boston</span>

Greater Boston, primarily Boston and Cambridge, is home to more than 1,000 biotechnology companies, ranging from small start-ups to billion-dollar pharmaceutical companies. The many universities in the area give the region a large network of scientists.

Timothy Rowe is a technology entrepreneur. He is the founder and CEO of Cambridge Innovation Center as well as the founder of Venture Café. He also serves as a partner of New Atlantic Ventures, Chair of LabCentral, and Chair of MassRobotics.

Cortex Innovation Community, Cortex Innovation District, or Cortex is an innovation district in the Midtown neighborhood of Saint Louis, Missouri. A 200-acre hub for technology and biological science research, development, and commercialization, Cortex is a main location for the city's technology startup companies. It is near Washington University's medical campus, St. Louis University, and Barnes-Jewish Hospital.

<span class="mw-page-title-main">Technology Square (Cambridge, Massachusetts)</span> Office building complex in Cambridge, Mass.

Technology Square, nicknamed Tech Square, is a commercial office building complex in the Kendall Square neighborhood of Cambridge, Massachusetts, immediately adjacent to the campus of the Massachusetts Institute of Technology (MIT), which is one of the most prestigious colleges in the world.

The Exploratory Science Center (ESC) is a pharmaceutical company based in Cambridge, MA. The disease agnostic research site was founded in 2016, and was led by Daria Hazuda until 2021. In late 2021 Juan Alvarez took on leadership as the interim head and Marc Levesque took on leadership in 2022. The Exploratory Science Center is a subsidiary of Merck & Co.

Clustermarket is a lab management system which helps laboratories to optimize operations and accelerate their results.

References

  1. ↑ Galvin, William Francis. "Business Entity Summary". Massachusetts Secretary of the Commonwealth . Retrieved 16 August 2013.
  2. ↑ "LabCentral Team". LabCentral. Archived from the original on 4 December 2013. Retrieved 31 October 2013.
  3. ↑ Castanon, Oscar (10 January 2014). "LabCentral, tout juste ouvert, déjà un succès". Bulletins-Electroniques. Retrieved 16 January 2014.
  4. ↑ Keohane, Dennis (2014-06-13). "Where big ideas are hatched: Incubators and accelerators". BetaBoston. Retrieved 8 July 2014.
  5. ↑ Katz, Bruce; Wagner, Julie (2014-06-13). "Where the American Startup Dream is Moving: Downtown". Fortune Magazine . Retrieved 8 July 2014.
  6. 1 2 3 4 McQuilken, Angus G. "Governor Patrick to launch construction for LabCentral biotech hub with Senator Mary Landrieu today in Kendall Square, Cambridge" (PDF). The Massachusetts Life Sciences Center . Retrieved 16 August 2013.[ permanent dead link ]
  7. ↑ Szaniszlo, Szaniszlo (2013-02-08). "LabCentral to be $5M test tube for bio startups". Boston Herald . Retrieved 16 August 2013.
  8. 1 2 Kirsner, Scott (2012-09-20). "LabCentral, a new hatchery for science-oriented startups, is seeking space in Kendall Square". Boston Globe . Retrieved 16 August 2013.
  9. ↑ McQuilken, Angus G. "Massachusetts Life Sciences Center Awards $5 Million Grant For "LabCentral" Start-up Laboratory In Cambridge" (PDF). The Massachusetts Life Sciences Center. Archived from the original (PDF) on 24 April 2013. Retrieved 16 August 2013.
  10. ↑ "Kendall Square's LabCentral awarded $5 million grant to help startups". Cambridge Chronicle . 2013-02-09. Retrieved 16 August 2013.
  11. ↑ Barone, Steve. "Triumvirate Environmental Donates $2.5million as Founding Sponsor of LabCentral". Triumvirate Environmental. Retrieved 16 August 2013.
  12. ↑ "Edwards Wildman Sponsors LabCentral, First Large Scale Biotech-Capable Shared Lab Facility in Cambridge, Mass". Edwards Wildman Palmer. Retrieved 16 August 2013.
  13. 1 2 "LabCentral, Launchpad for Start-ups and Heart of the Cambridge Biotech Innovation Hub, Begins Accepting Applications for LabCentral Shared Laboratory Space; Signs New Sponsors". The Providence Journal . 2013-07-17. Retrieved 16 August 2013.
  14. ↑ "LabCentral: Building a new model for early stage biotech". EBD Group AG. 2013-06-17. Retrieved 16 August 2013.
  15. ↑ "Vaxess Moves to LabCentral". Twitter. Retrieved 13 August 2013.
  16. ↑ Fruehauf, Johannes. "First company selected for LabCentral: Vaxess". LabCentral. Archived from the original on 30 December 2013. Retrieved 14 August 2013.
  17. ↑ Borchers, Callum (2013-12-23). "Loan may help vaccines get to crisis areas". Boston Globe . Retrieved 28 December 2013.
  18. ↑ Burgstone, Jon (2012-04-25). "4 Harvard Start-ups to Watch". Inc.com. Retrieved 18 May 2012.
  19. ↑ "MIT $100K - Vaxess Technologies". Massachusetts Institute of Technology. Archived from the original on 12 May 2012. Retrieved 7 May 2012.
  20. ↑ Grossman, Caroline (2013-09-30). "LabCentral Adds Eppendorf as a Major Sponsor of the Cambridge Launchpad for Life Science Startups". Yahoo! Finance . Retrieved 10 October 2013.
  21. ↑ Fruehauf, Johannes. "Auxocell Admitted to LabCentral". LabCentral. Archived from the original on 6 October 2013. Retrieved 10 October 2013.
  22. ↑ Fruehauf, Johannes. "LabCentral resident Conkwest treats Cancer with Natural Killer Cells". LabCentral. Archived from the original on 4 December 2013. Retrieved 10 October 2013.
  23. ↑ "LabCentral Launches Laboratory Operations; Signs American Laboratory Trading as a Gold Sponsor". PR Newswire . 2013-11-19. Retrieved 25 November 2013.
  24. ↑ Grossman, Caroline (2012-12-04). "LabCentral Signs New Agreement in Support of Life-Sciences Startups". PRNewsWire. Retrieved 4 December 2013.
  25. ↑ Arnold, Chris (2013-10-31). "What Happens When The Pace Of Startups Slows Down". NPR . Retrieved 6 November 2013.
  26. ↑ Donnelly, Julie M. (2014-03-04). "Here are the six bets J&J made in Boston in the past year". Boston Business Journal . Retrieved 2 April 2014.
  27. ↑ "LabCentral Announces Sponsorship by Pfizer to Support Life-Science Startup Companies in Cambridge, Massachusetts". Providence Journal . 2014-04-01. Retrieved 2 April 2014.
  28. 1 2 Keohane, Dennis (2014-03-31). "LabCentral to Officially Open Biotech Space This Week". BetaBoston . Archived from the original on 4 April 2014. Retrieved 2 April 2014.
  29. ↑ "Governor Patrick Celebrates Grand Opening of LabCentral Biotech Hub, Announces $5 Million in Capital Funding". Providence Journal . 2014-04-02. Retrieved 3 April 2014.
  30. ↑ Baldassari, Erin (2013-04-03). "Patrick Celebrates Grand Opening Of LabCentral". Banker & Tradesman . Retrieved 3 April 2014.
  31. ↑ Baldassari, Erin (2013-02-14). "Historic building in Cambridge gets new use as shared lab space". Cambridge Chronicle . Retrieved 21 November 2013.
  32. ↑ Resende, Patricia (2013-02-07). "LabCentral gets $5M boost for new lab space". Boston Business Journal . Retrieved 16 August 2013.
  33. ↑ Fruehauf, Johannes. "Lab Central History" (PDF). Germany.info. Retrieved 5 December 2013.
  34. 1 2 "LabCentral, New Biotech Incubator, Opens up in Kendall Square". XConomy. 2013-11-20. Retrieved 25 November 2013.

42°21′43.7″N71°5′42.3″W / 42.362139°N 71.095083°W / 42.362139; -71.095083

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.